P S Mushlin|R D Olson - JoVE Visualize

Showing results (1-10 of 120) with videos related to

Pageof 12

Sort By:

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 1, 1990

Doxorubicin cardiotoxicity: analysis of prevailing hypothesesR D Olson, P S Mushlin

Journal of Cardiovascular Pharmacology|January 1, 1984

Treatment of postischemic reperfusion cardiac injury with a perfluorochemical solutionM D Parrish, R D Olson, P S Mushlin, et al.

Life Sciences|January 1, 1991

Aging alters the force-frequency relationship and toxicity of oxidative stress in rabbit heartB J Cusack, P S Mushlin, T Andrejuk, et al.

The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|September 1, 1996

Aging increases the cardiotoxicity of daunorubicin and daunorubicinol in the ratB J Cusack, P S Mushlin, C J Johnson, et al.

Life Sciences|June 3, 1985

Beneficial effects of perfluorochemical artificial blood on cardiac function following coronary occlusionP S Mushlin, R J Boucek, M D Parrish, et al.

British Journal of Pharmacology|November 1, 1993

Time-related increases in cardiac concentrations of doxorubicinol could interact with doxorubicin to depress myocardial contractile functionP S Mushlin, B J Cusack, R J Boucek, et al.

Pediatric Research|October 1, 1984

Comparative effects of verapamil, nifedipine, and diltiazem on contractile function in the isolated immature and adult rabbit heartR J Boucek, M Shelton, M Artman, et al.

Toxicology and Applied Pharmacology|February 1, 1993

Daunorubicin-induced cardiac injury in the rabbit: a role for daunorubicinol?B J Cusack, P S Mushlin, L D Voulelis, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988

Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinolR D Olson, P S Mushlin, D E Brenner, et al.

Biochemical Pharmacology|October 6, 2000

Daunorubicin cardiotoxicity: evidence for the importance of the quinone moiety in a free-radical-independent mechanismS E Shadle, B P Bammel, B J Cusack, et al.

Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:

Pageof 12

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 1, 1990

Doxorubicin cardiotoxicity: analysis of prevailing hypothesesR D Olson, P S Mushlin

Journal of Cardiovascular Pharmacology|January 1, 1984

Treatment of postischemic reperfusion cardiac injury with a perfluorochemical solutionM D Parrish, R D Olson, P S Mushlin, et al.

Life Sciences|January 1, 1991

Aging alters the force-frequency relationship and toxicity of oxidative stress in rabbit heartB J Cusack, P S Mushlin, T Andrejuk, et al.

The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|September 1, 1996

Aging increases the cardiotoxicity of daunorubicin and daunorubicinol in the ratB J Cusack, P S Mushlin, C J Johnson, et al.

Life Sciences|June 3, 1985

Beneficial effects of perfluorochemical artificial blood on cardiac function following coronary occlusionP S Mushlin, R J Boucek, M D Parrish, et al.

British Journal of Pharmacology|November 1, 1993

Time-related increases in cardiac concentrations of doxorubicinol could interact with doxorubicin to depress myocardial contractile functionP S Mushlin, B J Cusack, R J Boucek, et al.

Pediatric Research|October 1, 1984

Comparative effects of verapamil, nifedipine, and diltiazem on contractile function in the isolated immature and adult rabbit heartR J Boucek, M Shelton, M Artman, et al.

Toxicology and Applied Pharmacology|February 1, 1993

Daunorubicin-induced cardiac injury in the rabbit: a role for daunorubicinol?B J Cusack, P S Mushlin, L D Voulelis, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988

Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinolR D Olson, P S Mushlin, D E Brenner, et al.

Biochemical Pharmacology|October 6, 2000

Daunorubicin cardiotoxicity: evidence for the importance of the quinone moiety in a free-radical-independent mechanismS E Shadle, B P Bammel, B J Cusack, et al.

Pageof 12